Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

668 ARTÍCULOS , VIENDO DEL 436 AL 450

Phenotypic variability in a four generation family with a p.Thr666Met CACNA1A gene mutation

García-Baró-Huarte M, Iglesias-Mohedano AM, Slöcker-Barrio M, Vázquez-López M, García-Morín M, Miranda-Herrero MC, Castro-Castro P.

Pediatr Neurol. 2014 Oct;51(4):557-9. doi: 10.1016/j.pediatrneurol.2014.07.008. Epub 2014 Jul 16.

Compound heterozygous PNPLA6 mutations cause Boucher-Neuhäuser syndrome with late-onset ataxia

Deik A, Johannes B, Rucker JC, Sánchez E, Brodie SE, Deegan E, Landy K, Kajiwara Y, Scelsa S, Saunders-Pullman R, Paisán-Ruiz C.

J Neurol. 2014 Dec;261(12):2411-23. doi: 10.1007/s00415-014-7516-3. Epub 2014 Sep 30.

Isolated Post-Traumatic Syringobulbia; Case Report and Review of the Literature

Taghipour M, Derakhshan N, Ghaffarpasand F.

Bull Emerg Trauma. 2014 Oct;2(4):166-9.

[A first pilot study on the neonatal screening of primary immunodeficiencies in Spain: TRECS and KRECS identify severe T- and B-cell lymphopenia]

Olbrich P, de Felipe B, Delgado-Pecellin C, Rodero R, Rojas P, Aguayo J, Marquez J, Casanovas J, Sánchez B, Lucena JM, Ybot-Gonzalez P, Borte S, Neth O.

An Pediatr (Barc). 2014 Nov;81(5):310-7. doi: 10.1016/j.anpedi.2014.08.002. Epub 2014 Sep 30.

Association of type IV spinal muscular atrophy (SMA) with myoclonic epilepsy within a single family

Liyanage DS, Pathberiya LS, Gooneratne IK, Vithanage KK, Gamage R.

Int Arch Med. 2014 Sep 26;7(1):42. doi: 10.1186/1755-7682-7-42. eCollection 2014.

Susac's syndrome: the value of fundus fluorescein angiography

Khan IJ, Allroggen H, Pagliarini S.

BMJ Case Rep. 2014 Oct 3;2014:bcr2014206546. doi: 10.1136/bcr-2014-206546.

An 11-year review of levetiracetam ingestions in children less than 6 years of age

Lewis JC, Albertson TE, Walsh MJ.

Clin Toxicol (Phila). 2014 Nov;52(9):964-8. doi: 10.3109/15563650.2014.965828. Epub 2014 Oct 6.

A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia

Schimmer AD, Raza A, Carter TH, Claxton D, Erba H, DeAngelo DJ, Tallman MS, Goard C, Borthakur G.

PLoS One. 2014 Oct 6;9(10):e108694. doi: 10.1371/journal.pone.0108694. eCollection 2014.

Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis

Neuenschwander AG, Thai KK, Figueroa KP, Pulst SM.

JAMA Neurol. 2014 Dec;71(12):1529-34. doi: 10.1001/jamaneurol.2014.2082.

Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies

Zaccara G, Giovannelli F, Franco V, Cincotta M, Tramacere L, Verrotti A.

Epilepsy Res. 2014 Dec;108(10):1685-93. doi: 10.1016/j.eplepsyres.2014.09.015. Epub 2014 Sep 22.

[Carriers of fragile X syndrome can present with a broad spectrum of clinical disorders]

Jønch AE, Grønskov K, Carlsen Lunding JM, Nielsen JE, Brøndum-Nielsen K.

Ugeskr Laeger. 2014 Jun 23;176(26):V02140099.

Spontaneous pneumothorax in ataxia telangectasia

Chakravarthi S, Goyal MK.

Indian J Med Res. 2014 Aug;140(2):321-2.

[Diffuse superficial siderosis of the central nervous system: four case reports and review of the literature]

Calvo M, de Miguel C, Pinel A, Ortega J, Aladro Y.

Rev Neurol. 2014 Oct 16;59(8):354-8.

Targeting the Small- and Intermediate-Conductance Ca-Activated Potassium Channels: The Drug-Binding Pocket at the Channel/Calmodulin Interface

Cui M, Qin G, Yu K, Bowers MS, Zhang M.

Neurosignals. 2014;22(2):65-78. doi: 10.1159/000367896. Epub 2014 Oct 8.

Miller Fisher syndrome with presynaptic neuromuscular transmission disorder

Ehler E, Latta J.

J Clin Neurosci. 2014 Nov;21(11):2025-7. doi: 10.1016/j.jocn.2014.05.050. Epub 2014 Oct 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias